Elevated FOSB-expression; a potential marker of valproate sensitivity in AML.
Khanim FL, Bradbury CA, Arrazi J, Hayden RE, Rye A, Basu S, MacWhannell A, Sawers A, Griffiths M, Cook M, Freeman S, Nightingale KP, Grimwade D, Falciani F, Turner BM, Bunce CM, Craddock C.
Khanim FL, et al. Among authors: bradbury ca.
Br J Haematol. 2009 Feb;144(3):332-41. doi: 10.1111/j.1365-2141.2008.07449.x. Epub 2008 Nov 22.
Br J Haematol. 2009.
PMID: 19036090
Free article.
Clinical Trial.